S&P 500 7,642.26 −0.28%
Nasdaq 26,023.84 +0.06%
S&P/TSX 35,815.08 −0.44%
Apple 347.08 −0.33%
Nvidia 211.92 −0.14%
Microsoft 524.04 +0.57%
Shopify 236.22 −0.08%
Royal Bank 280.81 −0.70%
CAD/USD 0.7143 +0.30%
LIVE · 12:25 ET
Market ClerkRecap
Fri Oct 23 · markets open6 signals today103 insider buys this week · $208.8MCIRO short report next: Oct 31The week ahead

ARVN

ARVINAS, INC.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
7.72
+0.16 +2.12%
USD · close Oct 22

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $504.8MP/E 32.2DIV YIELD —FCF YIELD -41.36%REV TTM $316.7M −15.0%NET INCOME $9.3MNET CASH $93.8M52W 6.82 – 13.83SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 47 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$249.7M+1014.7%—$164.1M$169.4M—2.58−$48.3M$200K−$48.5MAug 4
Q1 2026 · Mar 31$15.6M−91.7%—−$63.8M−$57.6M−169.5%-0.90−$69.2M$1.3M−$70.5MMay 11
Q4 2025 · Dec 31derived$9.5M−84.0%—−$74.6M−$67.4M—-0.96−$30.4M$200K−$30.6MFeb 24
Q3 2025 · Sep 30$41.9M−59.1%—−$43.8M−$35.1M—-0.48−$59.1M$100K−$59.2MNov 5
Q2 2025 · Jun 30$22.4M−70.7%—−$71.5M−$61.2M—-0.84−$95.4M$1.2M−$96.6MAug 4
Q1 2025 · Mar 31$188.8M+646.2%—$71.4M$82.9M—1.14−$88.9M$400K−$89.3MMay 11
Q4 2024 · Dec 31derived$59.2M——−$58.2M−$45.1M—-0.63−$84.1M$300K−$84.4MFeb 24
Q3 2024 · Sep 30$102.4M+196.0%—−$60.3M−$49.2M—-0.68−$128M$700K−$128.7MNov 5
Q2 2024 · Jun 30$76.5M——−$48.5M−$35.2M—-0.49$50.3M$700K$49.6MAug 6
Q1 2024 · Mar 31$25.3M——−$83.3M−$69.4M—-0.97−$97.5M$100K−$97.6MMay 1
Q4 2023 · Dec 31derived−$43.1M——−$165.3M−$154.8M—-2.65−$83.1M$100K−$83.2MFeb 24
Q3 2023 · Sep 30$34.6M——−$73.9M−$64M—-1.18−$84.8M$1.1M−$85.9MOct 30

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$262.6M—−$118.5M−$80.8M-30.8%-1.14−$273.8M$1.9M−$275.7M$91.9M—
FY2024 · to Dec 31$263.4M—−$250.2M−$198.9M-75.5%-2.77−$259.3M$1.8M−$261.1M$0—
FY2023 · to Dec 31$78.5M—−$401.5M−$367.3M-467.9%-6.62−$347.8M$2.9M−$350.7M$0—
FY2022 · to Dec 31$131.4M—−$263.2M−$282.5M-215.0%-5.31−$273.5M$6.8M−$280.3M——
FY2021 · to Dec 31$53.6M—−$188.4M−$191M-356.3%-3.82$559.4M$4.7M$554.7M——
FY2020 · to Dec 31$25.9M—−$120.8M−$119.3M-460.6%-3.02−$89.7M$6.4M−$96.1M——

Every number comes from ARVINAS, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch ARVN. Know when insiders buy.
One email the day a filing lands. Free.